Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico

2 abstracts

Abstract
Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study.
Org: Sylvester Cancer Center, AOU Careggi, Division of Hematology and Hematologic Malignancies, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Josep Carreras Leukemia Research Institute,
Abstract
Bromodomain and extra-terminal (BET) inhibitor INCB057643 (LIMBER-103) in patients (pts) with relapsed or refractory myelofibrosis (R/R MF) and other advanced myeloid neoplasms: A phase 1 study.
Org: Sylvester Cancer Center, Emory University School of Medicine, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hospital Germans Trias i Pujol, Institut Català D'Oncologia,